• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Ribonucleic Acid
Tag:

Ribonucleic Acid

Health

Scientists map 239 human-infective RNA viruses to track future outbreak risks

by Chief Editor April 27, 2026
written by Chief Editor

The Hidden Map of Viral Threats: Decoding the RNA Landscape

The battle against emerging infectious diseases is often a race against an invisible enemy. A comprehensive new global dataset has recently brought the number of known human-infective RNA virus species to 239. This isn’t just a list; it is a roadmap showing how animal hosts, transmission routes, and surveillance gaps dictate whether a virus remains a rare occurrence or becomes a global crisis.

While the number of recognized species has grown—increasing by 25 since 2018—the data reveals a striking pattern. Most of these viruses are not random anomalies; they cluster within a few specific families and are heavily linked to non-human hosts, particularly mammals.

Did you know? The first human RNA virus ever reported was the Yellow fever virus back in 1901. Since then, discovery rates peaked significantly in the 1960s and again in the early 2000s.

Why Mammals are the Primary Bridge

The data underscores a critical biological reality: mammals are the central players in viral emergence. Most human-infective RNA viruses are associated with non-human mammalian hosts, creating a natural bridge for “spillover” events.

Why Mammals are the Primary Bridge
Level Vector Why Mammals

However, spillover does not automatically lead to a pandemic. The research highlights a critical bottleneck between the initial exposure and sustained human-to-human spread. While many viruses can jump from an animal to a human, only a slight fraction possess the traits necessary to adapt and thrive within human populations.

The Bottleneck: From Spillover to Epidemic Potential

Not all viruses are created equal. Scientists now classify transmissibility into levels to better predict risk. According to the latest findings, 62% of these RNA viruses are strictly zoonotic (Level 2), meaning they can infect a human but cannot spread to another person.

In contrast, only 60 species have reached Level 4, meaning they are either endemic in humans or capable of causing epidemic spread. Even among these high-risk viruses, many still maintain animal reservoirs, making them persistent threats that cannot be easily eradicated.

The Dominance of Vector-Borne Spread

When looking at how these pathogens move, vector-borne transmission—primarily via ticks and mosquitoes—is the dominant route. Here’s followed by inhalation and direct contact pathways.

View this post on Instagram about Vector, The Dominance of Vector
From Instagram — related to Vector, The Dominance of Vector

Recent events involving the Oropouche virus and SARS-CoV-2 serve as stark reminders of how quickly these pathways can lead to widespread outbreaks. The diversity of these routes means that surveillance cannot focus on a single method of transmission if we hope to catch the next threat early.

Pro Tip: To understand the broader context of these threats, explore how metagenomics is used to identify viruses that don’t fit traditional profiles.

Predicting the Next Outbreak: The Future of Surveillance

The future of global health security is shifting from broad, reactive searches to targeted, proactive surveillance. Instead of searching blindly for any new pathogen, experts are now using datasets to pinpoint “high-risk” zones.

Chapter 25 – The RNA Viruses that Infect Humans

Targeting the “Dark Matter” of the Virosphere

The integration of artificial intelligence is revolutionizing discovery. For example, deep learning algorithms like LucaProt are now being used to identify highly divergent RNA viral “dark matter” by integrating sequence and predicted structural information. This allows scientists to find viruses that were previously invisible to standard detection methods.

By focusing on high-risk viral families and mammalian reservoirs in regions where surveillance is currently weak, health organizations can identify undetected spillovers before they evolve into epidemics.

The Role of Real-Time Genomic Sequencing

Closing the knowledge gaps around transmission routes and host ranges requires a commitment to real-time genomic sequencing. When we can map a virus’s genome the moment it emerges, we can determine its “Level” of transmissibility much faster, allowing for more precise public health interventions.

The Role of Real-Time Genomic Sequencing
Level Vector

For more detailed insights on viral classification, you can refer to the full catalogue in Scientific Data.

Frequently Asked Questions

How many RNA viruses are known to infect humans?
As of the complete of 2024, there are 239 recognized species of human-infective RNA viruses.

What is a “zoonotic” virus?
A zoonotic virus is one that is transmitted from animals to humans. Most human RNA viruses (62%) are strictly zoonotic and do not spread from human to human.

Which transmission route is most common for these viruses?
Vector-borne transmission, specifically through mosquitoes and ticks, is the most dominant route of spread.

Why are RNA viruses considered a greater threat than others?
Their ability to rapidly change, their diverse host ranges (especially in mammals), and their potential for epidemic spread—as seen with influenza and SARS-CoV-2—make them a primary focus for public health.

Stay Ahead of the Curve

Do you think AI will eventually allow us to predict a pandemic before the first human case occurs? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates in viral research and global health.

April 27, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

COVID vaccination during pregnancy not associated with neurodevelopmental problems in children

by Chief Editor February 12, 2026
written by Chief Editor

COVID-19 Vaccine in Pregnancy: New Research Reassures Parents

Recent findings presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™ offer strong evidence that mRNA COVID-19 vaccination during pregnancy does not increase the risk of autism or other neurodevelopmental issues in children. This research addresses a significant concern for expectant parents and provides valuable data to support informed decision-making.

The Study: A Deep Dive into Neurodevelopmental Outcomes

Researchers from the Maternal-Fetal Medicine Units Network conducted a prospective observational study involving 434 children aged 18 to 30 months. The study meticulously compared 217 children born to mothers who received at least one dose of the mRNA COVID-19 vaccine during or within 30 days prior to pregnancy with 217 children born to mothers who remained unvaccinated during that period.

To ensure a robust comparison, mothers were matched based on key factors including delivery location (hospital, birth center, etc.), delivery date, insurance status and race. The study excluded pregnancies with preterm deliveries (under 37 weeks), multiple births, or children born with major congenital malformations.

How Were Children Assessed?

Neurodevelopmental assessments were conducted on all children between 1.5 and 2.5 years of age. Researchers utilized the Ages and Stages Questionnaire Version 3, a tool designed to track child development across five key areas: communication, gross motor skills, fine motor skills, problem-solving, and personal-social interaction.

the Child Behavior Checklist, Modified Checklist for Autism in Toddlers, and Early Childhood Behavior Questionnaire were used to provide a comprehensive evaluation of each child’s development.

Key Findings: No Detectable Link

The study’s lead researcher, Dr. George R. Saade, emphasized that “Neurodevelopment outcomes in children born to mothers who received the COVID-19 vaccine during or shortly before pregnancy did not differ from those born to mothers who did not receive the vaccine.” This finding provides significant reassurance to parents and healthcare providers.

Brenna L. Hughes, MD, MSc, highlighted the study’s rigor, stating, “This study, conducted through a rigorous scientific process in an NIH clinical trials network, demonstrates reassuring findings regarding the long-term health of children whose mothers received COVID-19 vaccination during pregnancy.”

mRNA vs. Subunit Vaccines: Understanding Your Options

Both mRNA and subunit COVID-19 vaccines are recommended for use during all stages of pregnancy to protect both maternal and infant health. The research specifically focused on the mRNA vaccine, but the broader recommendation supports the safety of both types.

Future Trends and Ongoing Research

This study builds upon a growing body of evidence supporting the safety and efficacy of COVID-19 vaccination during pregnancy. Future research will likely focus on long-term developmental outcomes, potentially tracking children for several years to further solidify these findings.

There is also increasing interest in understanding the potential benefits of vaccination beyond preventing COVID-19 infection, such as the transfer of antibodies to the infant, providing early protection. Further investigation into the impact of vaccination timing – different trimesters – may also refine recommendations.

Did you know?

The study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, underscoring the importance of federal investment in maternal and child health research.

FAQ

Q: Is the COVID-19 vaccine safe during pregnancy?
A: Yes, both mRNA and subunit COVID-19 vaccines are recommended and considered safe during all stages of pregnancy.

Q: What age were the children in this study?
A: The children in the study were between 18 and 30 months ancient.

Q: What neurodevelopmental areas were assessed?
A: The study assessed communication, gross motor skills, fine motor skills, problem-solving, and personal-social interaction.

Q: Does this study prove that the vaccine has no effect on a child’s development?
A: This study found no *detectable* association between maternal mRNA vaccination and neurodevelopmental differences. Ongoing research will continue to monitor long-term outcomes.

Pro Tip: Discuss your individual risk factors and concerns with your healthcare provider to make the best decision for you and your baby.

Learn more about COVID-19 vaccines and pregnancy from the Society for Maternal-Fetal Medicine.

Was this article helpful? Share your thoughts in the comments below!

February 12, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Large Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates

by Chief Editor February 9, 2026
written by Chief Editor

COVID Vaccines and Fertility: Swedish Study Confirms No Link, But Concerns Persist

Reassuring data from a large-scale Swedish study has reinforced the scientific consensus: COVID-19 vaccination does not negatively impact childbirth rates. Published in Communications Medicine, the research analyzed data from nearly 60,000 women and found no statistically significant association between vaccination and either childbirth or miscarriage.

Addressing Early Misinformation

Early in the pandemic, unfounded rumors spread rapidly, particularly on social media, suggesting that mRNA vaccines could impair fertility. These claims often centered on the idea that the vaccine might trigger an immune response against a protein found in the placenta. Later, as some countries experienced declines in birth rates, suspicions arose that the vaccines could be a contributing factor. This new study directly addresses those concerns.

How the Swedish Study Was Conducted

Researchers at Linköping University examined data from women aged 18 to 45 in Jönköping County, Sweden, between 2016, and 2024. The study utilized a robust methodology, employing Cox proportional hazards models to compare childbirth rates between vaccinated and unvaccinated women. The index event was defined as an estimated conception date, approximately 280 days before childbirth. Researchers also accounted for potential biases and conducted sensitivity analyses using different average pregnancy lengths (280 and 266 days).

Key Findings: No Association Found

The study revealed that approximately 75.5% of the women included had received at least one dose of a COVID-19 vaccine. Despite a decline in childbirths observed between 2021 and 2024, the researchers found no significant difference in childbirth rates between vaccinated and unvaccinated groups. Similarly, no association was detected between vaccination and miscarriage rates. Hazard ratios remained close to one, indicating no increased or decreased risk associated with vaccination.

Beyond the Vaccine: Understanding Declining Birth Rates

While the study definitively addresses vaccine-related concerns, it also highlights the complexity of factors influencing birth rates. The researchers suggest that observed declines are more likely attributable to broader societal and economic shifts, including changes in family planning, economic uncertainty, and the behavioral changes associated with pandemic lockdowns.

Historical Context and Demographic Trends

Sweden, like many developed nations, has experienced fluctuating birth rates over the decades. A rise in the 1980s was followed by declines in the 1990s, linked to factors like reduced social support for families. The study notes that the pool of prospective parents between 2021 and 2024 was already shrinking due to lower birth rates in previous generations.

What Does This Mean for the Future?

The consistent findings from multiple studies, including this recent Swedish research, provide strong evidence supporting the safety of COVID-19 vaccines for women of childbearing age. However, the persistence of misinformation underscores the importance of continued public health communication and education.

The Role of Public Health Messaging

Combating misinformation requires proactive and transparent communication from public health officials. Sharing data-driven evidence, addressing concerns directly, and utilizing trusted sources are crucial steps in building public confidence in vaccines and other health interventions.

FAQ

Q: Do COVID-19 vaccines affect fertility?
A: No. Multiple studies, including a large study in Sweden, have found no association between COVID-19 vaccination and reduced fertility or increased miscarriage rates.

Q: Why did birth rates decline during the pandemic?
A: Declining birth rates are likely due to a combination of factors, including economic uncertainty, changes in family planning, and the behavioral impacts of pandemic lockdowns.

Q: Is the mRNA vaccine safe during pregnancy?
A: Yes, mRNA vaccines are considered safe during pregnancy and are recommended by health authorities.

Q: What methodology was used in the Swedish study?
A: Researchers used Cox proportional hazards models to compare childbirth rates between vaccinated and unvaccinated women, treating vaccination as a time-varying exposure.

Did you grasp? The Swedish study analyzed data from nearly 60,000 women, making it one of the largest investigations into this topic.

Pro Tip: Always consult with your healthcare provider for personalized medical advice and to address any concerns you may have about vaccines and fertility.

Want to learn more about COVID-19 vaccines and reproductive health? Explore our other articles on vaccine safety and women’s health.

Share your thoughts in the comments below! What questions do you still have about COVID-19 vaccines and fertility?

February 9, 2026 0 comments
0 FacebookTwitterPinterestEmail
Tech

Novel RNA molecule may influence patient survival in certain blood cancers

by Chief Editor February 3, 2026
written by Chief Editor

The Hidden Language of Our Genes: How ‘Dark RNA’ Could Revolutionize Cancer Treatment

For decades, the central dogma of molecular biology held that DNA makes RNA, and RNA makes protein. But a growing body of research is revealing a far more complex picture. Scientists are discovering a vast world of “non-coding” RNAs – molecules transcribed from DNA that don’t become proteins – and their roles are proving surprisingly crucial to health and disease. A recent breakthrough from Texas A&M University Health Science Center highlights this shift, identifying a novel RNA molecule, CUL1-IPA, that safeguards a vital cellular structure and may even predict outcomes in blood cancers.

Beyond the Protein Code: The Rise of Non-Coding RNAs

Think of DNA as the master blueprint for a building. Proteins are the construction workers, carrying out the instructions. RNA was long considered the messenger, delivering those instructions. But what if there were also architects and structural engineers – molecules ensuring the building’s foundation remains strong? That’s where non-coding RNAs come in. They regulate gene expression, maintain cellular structures, and influence a host of other processes without ever being translated into proteins.

CUL1-IPA, discovered within the gene that codes for the CUL1 protein, is a prime example. Unlike its protein-producing counterpart, CUL1-IPA remains within the cell’s nucleus, specifically supporting the nucleolus – the ribosome factory. Removing CUL1-IPA caused the nucleolus to disintegrate, demonstrating its essential structural role. This finding underscores a fundamental shift in our understanding of gene function: a single gene can have multiple outputs, each with a unique purpose.

Did you know? It’s estimated that over 80% of the human genome is transcribed into RNA, but only about 2% codes for proteins. This means the vast majority of RNA activity was previously considered “junk DNA,” but is now recognized as having critical regulatory functions.

CUL1-IPA and Blood Cancers: A Potential Biomarker and Therapeutic Target

The implications of this discovery extend beyond basic biology. Researchers analyzed data from patients with multiple myeloma and chronic lymphocytic leukemia and found a striking correlation: higher levels of CUL1-IPA were present in patients with more aggressive forms of these cancers. This suggests CUL1-IPA could serve as a biomarker – a measurable indicator of disease severity or prognosis.

Why might this be? Cancer cells require a massive output of ribosomes to rapidly divide and proliferate. CUL1-IPA, by supporting nucleolar function, may inadvertently fuel this growth. This makes it a potential therapeutic target. Drugs designed to inhibit CUL1-IPA could potentially slow or halt cancer progression. Similar strategies are already being explored for other non-coding RNAs involved in cancer development. For example, research into microRNAs (another type of non-coding RNA) has led to several clinical trials investigating their use in cancer therapy. National Cancer Institute

The Future of ‘Dark RNA’ Research: Personalized Medicine and Beyond

The discovery of CUL1-IPA is just the tip of the iceberg. Scientists are actively mapping the “dark RNA” landscape – identifying and characterizing the functions of these non-coding molecules. Advances in technologies like RNA sequencing and bioinformatics are accelerating this process. This research is paving the way for a new era of personalized medicine.

Imagine a future where a simple blood test can measure the levels of specific non-coding RNAs to predict your risk of developing cancer, determine the most effective treatment, or monitor your response to therapy. This is the promise of ‘dark RNA’ research.

Pro Tip: Keeping up with advancements in genomics and RNA biology can be challenging. Reputable sources like the National Human Genome Research Institute and scientific journals like Nature and Science offer reliable information.

Beyond Cancer: Expanding Roles for Non-Coding RNAs

The influence of non-coding RNAs isn’t limited to cancer. They’re implicated in a wide range of diseases, including neurodegenerative disorders like Alzheimer’s and Parkinson’s, cardiovascular disease, and autoimmune conditions. For instance, long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in regulating immune responses and inflammation. National Center for Biotechnology Information

Furthermore, research suggests non-coding RNAs play a critical role in embryonic development and cellular differentiation. Understanding these processes could lead to breakthroughs in regenerative medicine and tissue engineering.

FAQ: Decoding the World of Non-Coding RNA

  • What is non-coding RNA? RNA that is transcribed from DNA but does not code for proteins. It plays crucial regulatory roles in the cell.
  • Why is CUL1-IPA important? It supports the structural integrity of the nucleolus, essential for ribosome production, and its levels correlate with cancer severity.
  • Could non-coding RNAs be used as drugs? Yes, researchers are actively exploring ways to target non-coding RNAs with therapeutic interventions.
  • Is this research still in its early stages? While significant progress has been made, much remains to be discovered about the full scope of non-coding RNA function.

What are your thoughts on the potential of non-coding RNA research? Share your comments below!

Explore more: Read our article on the latest advancements in genomic sequencing | Learn about the role of RNA in immunotherapy

Stay informed: Subscribe to our newsletter for the latest breakthroughs in medical research.

February 3, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Scientists link specific gene variants to post-vaccine myocarditis and pericarditis

by Chief Editor May 12, 2025
written by Chief Editor

Unlocking the Genetic Puzzle: Myocarditis and COVID-19 Vaccines

New research into genetic predispositions for myocarditis and pericarditis post-COVID-19 vaccination is providing fresh insights into how our bodies respond to vaccines. This pivotal study not only broadens our understanding of immune responses but also stresses the significance of personalized healthcare.

Understanding the Study

A breakthrough study published in NPJ Vaccines has identified specific genetic variants linked to increased risks of myocarditis and pericarditis following COVID-19 mRNA vaccines. The research, which analyzed genetic data from a Swedish cohort, pinpoints variations near the SCAF11 gene and the LRRC4C gene as crucial risk factors.

Real-life Insight: For example, individuals with certain variants in these genes may experience heightened inflammatory responses, potentially leading to heart inflammation. This connection underscores the necessity for tailored vaccine strategies.

Implications for Vaccine Strategy

The discovery of genetic markers associated with adverse vaccine reactions offers opportunities to refine vaccine protocols. Personalized approaches could enhance vaccine safety and increase public confidence in vaccination programs.

According to the World Health Organization, understanding the genetic basis of vaccine reactions is a step toward personalized medicine, where treatments and preventive measures are tailored to individual genetic profiles.

Future Research Directions

Further research is crucial to confirm these genetic associations across larger and more diverse populations. Additional studies are needed to validate these findings and explore the biological pathways involved.

Related Keyword: Emerging trends in genomics and immunology will likely drive future vaccine safety assessments and development of personalized vaccination schedules based on genetic predispositions.

How Can We Apply This Knowledge?

Implementing genetic screening before vaccination could become a viable method for identifying individuals at higher risk of adverse reactions, allowing healthcare providers to monitor and manage these patients more closely.

Pro Tip: Stay informed about advances in genetic testing technologies, as these are rapidly evolving and becoming more accessible to healthcare professionals and the public alike.

FAQs

What are myocarditis and pericarditis?

Myocarditis is inflammation of the heart muscle, while pericarditis is inflammation of the outer layer of the heart. Both conditions can occur as rare side effects following certain vaccines.

Are these genetics widely present in the population?

The genetic variants identified are rare, but their identification helps identify those at higher risk, paving the way for preventive strategies and patient education.

Will everyone need genetic testing before vaccinations?

Not immediately. More research is needed to make genetic screening a standard practice, but it highlights the potential for personalized medicine.

Engaging with the Future of Genetics and Vaccines

As genetic research continues to unveil the mysteries of vaccine reactions, the ultimate goal remains to reach a future where vaccines are safe and effective for everyone. By utilizing genetic markers to preemptively identify risks, we can enhance the protective efficacy of vaccines and foster a more resilient public health strategy.

Did you know? Advances in genomics are accelerating our understanding of individual immune responses, which could significantly influence future healthcare practices.

If you found this insightful, consider exploring more content on our blog. Join our newsletter for the latest updates on healthcare and genomics. Engage with us: what are your thoughts on personalized medicine and vaccination? Leave a comment below!

May 12, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • CRISPR Study Unlocks Precision Chromosome Editing in Wheat

    April 28, 2026
  • Plasma Proteins in Urological Cancer Risk

    April 28, 2026
  • Lomiarz Released From Prison Under Electronic Monitoring

    April 28, 2026
  • Woman Gives Birth on Flight Just Before Landing in US

    April 28, 2026
  • Madonna og Sabrina Carpenter: Ny duett etter Coachella

    April 28, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World